Literature DB >> 15072665

Italian Group for Lap-Band System: results of multicenter study on patients with BMI < or =35 kg/m2.

L Angrisani1, F Favretti, F Furbetta, A Iuppa, S B Doldi, M Paganelli, N Basso, M Lucchese, M Zappa, G Lesti, F D Capizzi, C Giardiello, N Di Lorenzo, A Paganini, L Di Cosmo, A Veneziani, S Lacitignola, G Silecchia, M Alkilani, P Forestieri, F Puglisi, A Gardinazzi, M Toppino, F Campanile, B Marzano, P Bernante, G Perrotta, V Borrelli, M Lorenzo.   

Abstract

BACKGROUND: The Lap-Band System is the most common bariatric operation world-wide. Current selection criteria do not include patients with BMI < or = 35. We report the Italian multicentre experience with BMI < or = 35 kg/m(2) over the last 5 years. PATIENTS AND METHODS: Data were obtained from 27 centres involved in the Italian Collaborative Study Group for Lap-Band System. Detailed information was collected on a specially created electronic data sheet (MS Access 2000) on patients operated in Italy since January 1996. Items regarding patients with BMI < or = 35 were selected. Data were expressed as mean +/- SD except as otherwise indicated.
RESULTS: 225 (6.8%) out of 3,319 Lap-Band patients were recruited from the data-base. 15 patients, previously submitted to another bariatric procedure (BIB =14; VBG= 1) were excluded. 210 patients were eligible for study (34M/176F, mean age 38.19+/-11.8, range 17-66 years, mean BMI 33.9+/-1.1, range 25.1-35 kg/m(2), mean excess weight 29.5+/-7.1, range 8-41). 199 comorbidities were diagnosed preoperatively in 55/210 patients (26.2%). 1 patient (0.4%) (35 F) died 20 months postoperatively from sepsis following perforation of dilated gastric pouch. There were no conversions to laparotomy. Postoperative complications presented in 17/210 patients (8.1%). Follow-up was obtained at 6, 12, 24, 36, 48 and 60 months. At these time periods, mean BMI was 31.1+/-2.15, 29.7+/-2.19, 28.7+/-3.8, 26.7+/-4.3, 27.9+/-3.2, and 28.2+/-0.9 kg/m(2) respectively. Co-morbidities completely resolved 1 year postoperatively in 49/55 patients (89.1%). At 60 months follow-up, only 1 patient (0.4%) has a BMI >30.
CONCLUSIONS: Although surgical indications for BMI < or = 35 remain questionable, the Lap-Band in this study demonstrated that all but 1 patient achieved normal weight, and most lost their co-morbidities with a very low mortality rate.

Entities:  

Mesh:

Year:  2004        PMID: 15072665     DOI: 10.1381/096089204322917963

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  20 in total

Review 1.  The reporting of gastric band slip and related complications; a review of the literature.

Authors:  Richard John Egan; Simon J W Monkhouse; Hayley E Meredith; Sharon E Bates; Justin D T Morgan; Sally A Norton
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

Review 2.  A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.

Authors:  Wen-Sheng Rao; Cheng-Xiang Shan; Wei Zhang; Dao-Zhen Jiang; Ming Qiu
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

Review 3.  Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies.

Authors:  M Fried; G Ribaric; J N Buchwald; S Svacina; K Dolezalova; N Scopinaro
Journal:  Obes Surg       Date:  2010-06       Impact factor: 4.129

4.  Heat shock preconditioning reduces ischemic tissue necrosis by heat shock protein (HSP)-32-mediated improvement of the microcirculation rather than induction of ischemic tolerance.

Authors:  Yves Harder; Michaela Amon; Rene Schramm; Mirko Georgi; Andrej Banic; Dominique Erni; Michael D Menger
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 5.  [Evidential basis in bariatric surgery].

Authors:  M K Müller; S Wildi; P-A Clavien; M Weber
Journal:  Chirurg       Date:  2005-07       Impact factor: 0.955

6.  Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome after biliopancreatic diversion in patients with BMI < 35 kg/m2.

Authors:  Nicola Scopinaro; Francesco Papadia; Giuseppe Marinari; Giovanni Camerini; Gianfranco Adami
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

7.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

Review 8.  Long-term outcomes of laparoscopic adjustable silicone gastric banding (LAGB) in moderately obese patients with and without co-morbidities.

Authors:  Luigi Angrisani; Pier Paolo Cutolo; Giampaolo Formisano; Gabriella Nosso; Antonella Santonicola; Giuliana Vitolo
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

9.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Endocr Pract       Date:  2013 Mar-Apr       Impact factor: 3.443

Review 10.  Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.

Authors:  Rodrigo Muñoz; Alex Escalona
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.